Real‐world experience with the new Watchman FLX device: Data from two high‐volume Sicilian centers. The FLX‐iEST registry

The Watchman‐FLX left atrial appendage closure (LAAC) device presents innovative features: higher conformability, reduced length, closed distal "flex‐ball" during deployment, and flattened surface. We report our real‐world experience with the Watchman‐FLX device in two centers with consolidated LAAC expertise.

[1]  A. Huber,et al.  Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study. , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  C. Tamburino,et al.  Bailout additional Watchman FLX device implantation for left atrial appendage closure. , 2022, Cardiovascular revascularization medicine : including molecular interventions.

[3]  V. Reddy,et al.  Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device , 2021, Circulation.

[4]  T. Betts,et al.  Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device. , 2020, JACC. Cardiovascular interventions.

[5]  J. Nielsen-Kudsk,et al.  The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation. , 2020, JACC. Clinical electrophysiology.

[6]  M. Price,et al.  The NCDR Left Atrial Appendage Occlusion Registry. , 2020, Journal of the American College of Cardiology.

[7]  A. Komosa,et al.  The Watchman FLX: the initial Polish experience with the new device for left atrial appendage occlusion. , 2020, Kardiologia polska.

[8]  A. Camm,et al.  EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  S. Kische,et al.  Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage , 2019, Circulation. Arrhythmia and electrophysiology.

[10]  M. Alkhouli,et al.  Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. , 2018, JACC. Clinical electrophysiology.

[11]  Pascal Defaye,et al.  Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[12]  P. Mazzone,et al.  Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry , 2018, Journal of Interventional Cardiac Electrophysiology.

[13]  Saibal Kar,et al.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.

[14]  Dhanunjaya R. Lakkireddy,et al.  Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[17]  S. Kische,et al.  Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry , 2016, European heart journal.

[18]  M. Price,et al.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. , 2014, Journal of the American College of Cardiology.